The present invention provides a kind of evil (MS) for treating multiple sclerosis in individual or clinically isolated syndromes (CIS) is presented, including subjects laquinimod is used as and adds or be bound to inhibin. The present invention also provides a kind of encapsulation and pharmaceutical compositions, comprising laquinimod and inhibit extract for treating puzzlement object MS or CIS is presented. It is used as additional treatment the present invention also provides laquinimod or combines and inhibits extract for treating puzzlement object MS or presentation CIS. The present invention also provides use laquinimod and inhibin in preparation for treating the MS of subject or the evil of CIS being presented.
